2026 年至 2032 年腹腔镜设备市场（按类型、应用、最终用户和地区）

腹腔镜设备市场评估—2026-2032

微创手术技术日益偏好越来越多的患者选择腹腔镜手术而非传统开放性手术，因为腹腔镜手术具有术后疼痛轻、恢復时间短、疤痕少等诸多优势。预计2023年市场规模将超过154亿美元，到2032年将达到276.7亿美元。

此外，高清摄影机和机器人辅助手术设备等技术创新正在提高腹腔镜手术的精确度和有效性。此外，肥胖和胃肠道疾病等慢性疾病的日益流行正在推动对腹腔镜手术的需求，导致市场不断扩大，预计从 2026 年到 2032 年的复合年增长率约为 8.39%。

腹腔镜设备市场定义/概述

腹腔镜设备是用于微创外科手术的专用器械，外科医师借助摄影机和各种手术器械，透过小切口进行手术。这些器械的常见应用包括减重手术、妇科手术、泌尿系统手术和胃肠手术。与传统的开放性手术相比，腹腔镜设备具有恢復时间短、术后疼痛轻、疤痕小等特性。机器人辅助系统、增强影像技术以及人工智慧等技术进步可望改善手术效果，扩大腹腔镜手术的范围，使腹腔镜设备市场前景看好。

慢性病盛行率上升会推动腹腔镜设备市场的发展吗？

慢性病盛行率的上升推动了腹腔镜设备市场的成长，因为这些疾病通常需要手术介入才能有效治疗。肥胖、糖尿病和胃肠道疾病等慢性疾病在全球日益普遍。根据美国疾病管制与预防中心 (CDC) 的数据，到 2021 年，美国约有 42.4% 的成年人将被归类为肥胖，这意味着大量人口可以从腹腔镜减重手术中受益。此外，世界卫生组织 (WHO) 报告称，消化器官系统疾病是全球主要发病原因之一，这进一步推动了对腹腔镜设备辅助微创手术的需求。

此外，向早期疗育和预防性医疗保健的转变正在创造有利于腹腔镜技术应用的环境。随着医疗保健系统优先考虑经济高效的治疗方案和改善患者预后，腹腔镜手术因其住院时间缩短、恢復时间更快等优势，正逐渐被接受。

监管挑战会阻碍腹腔镜设备市场的成长吗？

监管环境无疑会阻碍腹腔镜器械市场的成长，因为製造商必须应对不同地区复杂的合规要求。例如，在美国，食品药物管理局(FDA) 对医疗设备核准有着严格的规定，这可能导致核准流程冗长且成本高昂。这种官僚主义障碍可能会减缓创新腹腔镜技术的市场推广，并影响製造商快速回应不断变化的医疗保健需求和市场需求的能力。

此外，临床试验和大量的文件要求可能会给小公司带来资源压力，限制其与拥有更完善监管策略的大公司竞争的能力。此外，随着全球监管机构日益重视病患安全和产品功效，製造商可能面临更严格的上市后装置审查。这可能导致更频繁的产品召回和安全警告，这不仅会影响消费者信心，还会给主要企业带来财务负担。

目录

第一章 全球腹腔镜设备市场介绍

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章腹腔镜设备全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章全球腹腔镜设备市场（按类型）

• 概述
• 腹腔镜
• 能源设备
• 钳子
• 存取装置

第六章全球腹腔镜设备市场（依应用）

• 概述
• 减重手术
• 一般外科
• 妇科手术
• 泌尿系统

第七章全球腹腔镜设备市场（依最终用户）

• 概述
• 医院
• 门诊中心

8. 全球腹腔镜设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章全球腹腔镜设备市场的竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• Karl Storz SE & Co
• Olympus Corporation
• Medtronic plc
• Braun Aesculap
• Stryker Corporation
• Richard Wolf GmbH
• Ethicon Inc.
• Smith & Nephew plc
• Cook Medical Incorporated
• ConMed Corporation
• Genesis MedTech
• Johnson & Johnson
• Boston Scientific Corporation
• Shenzen Midray Bio-medical Electronics Co. Ltd.
• Microline Surgical

第十一章 附录

• 相关调查

Laparoscopy Devices Market Valuation - 2026-2032

The growing preference for minimally invasive surgical techniques. Patients are increasingly choosing laparoscopic operations over traditional open surgeries because they offer various benefits such as less postoperative pain, shorter recovery times, and less scarring is surpassing USD 15.4 Billion in 2023 and reaching USD 27.67 Billion by 2032.

Furthermore, technological breakthroughs such as high-definition cameras and robotic-assisted surgical devices are improving the precision and efficacy of laparoscopic treatments. Furthermore, the increased prevalence of chronic conditions such as obesity and gastrointestinal problems is driving up demand for laparoscopic procedures, resulting in continuous market expansion is expected to grow at a CAGR of 8.39% about from 2026 to 2032.

Laparoscopy Devices Market: Definition/ Overview

Laparoscopy devices are specialized instruments used in minimally invasive surgical procedures, enabling surgeons to perform operations through small incisions with the aid of a camera and various surgical tools. Common applications of these devices include bariatric surgery, gynecological procedures, urological surgeries, and gastrointestinal surgeries, allowing for reduced recovery times, less postoperative pain, and minimized scarring compared to traditional open surgery. The future of the Laparoscopy Devices Market looks promising, driven by technological advancements such as robotic-assisted systems, enhanced imaging technologies, and the integration of artificial intelligence, which are expected to improve surgical outcomes and broaden the range of procedures performed laparoscopically.

Will Rising Prevalence of Chronic Diseases is Propelling the Laparoscopy Devices Market?

The rising prevalence of chronic diseases is indeed propelling the growth of the Laparoscopy Devices Market, as these conditions often require surgical intervention for effective management. Chronic diseases such as obesity, diabetes, and gastrointestinal disorders are becoming increasingly common worldwide. According to the Centers for Disease Control and Prevention (CDC), approximately 42.4% of adults in the United States were classified as obese in 2021, highlighting a significant population that may benefit from laparoscopic bariatric surgery. Additionally, the World Health Organization (WHO) reports that digestive diseases are among the leading causes of morbidity globally, further driving the demand for minimally invasive surgical procedures that laparoscopic devices facilitate.

Furthermore, the shift towards early intervention and preventive healthcare is fostering an environment conducive to the adoption of laparoscopic techniques. As healthcare systems prioritize cost-effective treatments and improved patient outcomes, laparoscopic surgery has gained traction due to its associated benefits, such as shorter hospital stays and quicker recovery times.

Will Regulatory Challenges Hamper the Growth of the Laparoscopy Devices Market?

Regulatory challenges are indeed poised to hamper the growth of the Laparoscopy Devices Market, as manufacturers must navigate a complex landscape of compliance requirements that vary by region. In the United States, for example, the Food and Drug Administration (FDA) has stringent regulations governing the approval of medical devices, which can lead to lengthy and costly approval processes. This bureaucratic hurdle can delay the introduction of innovative laparoscopic technologies to the market, impacting the ability of manufacturers to respond swiftly to evolving healthcare needs and market demands.

Additionally, the requirement for clinical trials and extensive documentation can strain the resources of smaller companies, limiting their capacity to compete with larger firms that have more robust regulatory strategies. Moreover, as regulatory bodies worldwide intensify their focus on patient safety and product efficacy, manufacturers may face increased scrutiny of their devices post-market. This can lead to more frequent product recalls or safety alerts, which not only affect consumer trust but also impose financial burdens on companies.

Category-Wise Acumens

Will Increasing Adoption of Energy Devices Boost the Laparoscopy Devices Market?

The increasing adoption of energy devices in laparoscopic surgeries is set to significantly boost the laparoscopic devices market. Energy devices, such as electrosurgical generators and advanced ultrasonic devices, play a crucial role in enhancing surgical efficiency by providing precise control over tissue cutting and coagulation. These devices minimize the risk of thermal damage to surrounding tissues, resulting in fewer complications and improved patient outcomes.

As more healthcare facilities recognize the advantages of these technologies, the demand for energy devices in laparoscopic procedures is expected to rise, driving overall market growth. Moreover, the trend toward minimally invasive surgeries is further propelling the adoption of energy devices. Surgeons increasingly prefer these devices due to their ability to streamline surgical processes and reduce operating times.

The insufflators are the fastest growing segment, driven by the rising adoption of minimally invasive surgical techniques and the growing need for effective carbon dioxide delivery to create and maintain a pneumoperitoneum.

Will Widespread Availability of Bariatric Surgery Fuel the Laparoscopy Devices Market?

The widespread availability of bariatric surgery is set to significantly fuel the Laparoscopy Devices Market. As obesity rates continue to rise globally, with the World Health Organization reporting that over 1.9 billion adults were classified as overweight in 2021, the demand for effective weight-loss solutions, particularly surgical interventions, has increased. Laparoscopic bariatric procedures, such as gastric bypass and sleeve gastrectomy, are favored for their minimally invasive nature, leading to shorter recovery times, reduced postoperative pain, and fewer complications.

This growing acceptance and preference for bariatric surgery among both healthcare providers and patients are driving an increased demand for advanced laparoscopic devices, which are essential for performing these procedures effectively. Moreover, the healthcare industry's focus on improving patient outcomes and reducing healthcare costs is further propelling the growth of the Laparoscopy Devices Market. As more hospitals and surgical centers adopt laparoscopic techniques for bariatric surgeries, the need for specialized devices will continue to rise.

The Gynecological Surgery is the fastest-growing segment, driven by a rise in conditions such as endometriosis, fibroids, and infertility treatments that require laparoscopic interventions.

Country/Region-wise

Will the Technological Advancement in North America Drive the Expansion of The Laparoscopy Devices Market?

Technological advancements are poised to significantly drive the expansion of the Laparoscopy Devices Market in North America. Innovations such as enhanced imaging systems, robotic-assisted surgery, and advanced surgical instruments are making minimally invasive procedures more efficient and safer for patients. For instance, the adoption of robotic surgical systems, which saw a 15% increase in utilization rates across hospitals in 2023 according to the American College of Surgeons, is enhancing the precision of laparoscopic surgeries, thereby increasing the overall demand for these devices.

Additionally, the increasing prevalence of chronic diseases such as obesity and gastrointestinal disorders is driving the demand for laparoscopic surgeries, as these procedures offer shorter recovery times and fewer complications compared to traditional surgeries. The U.S. Centers for Disease Control and Prevention (CDC) reports that approximately 42.4% of adults in the United States were classified as obese in 2021, a statistic that underscores the need for effective surgical interventions.

Will Increasing Number of Well-Equipped Hospitals in Asia Pacific Propel the Laparoscopy Devices Market?

The increasing number of well-equipped hospitals in the Asia Pacific region is expected to significantly propel the Laparoscopy Devices Market. According to the World Health Organization (WHO), the number of hospitals in Asia has grown rapidly, with an increase of over 30% in the last decade, largely due to rising healthcare expenditures and investments in advanced medical technologies. This surge in healthcare infrastructure is accompanied by a growing emphasis on minimally invasive surgical procedures, as they offer benefits such as reduced recovery times and lower complication rates.

Furthermore, government initiatives aimed at improving healthcare accessibility and quality are driving this trend. For instance, the Indian government's National Health Policy aims to increase the number of surgical procedures conducted in hospitals, with a target of reaching a surgical volume of 13 million by 2025. This focus on expanding surgical capabilities, along with a reported 12% increase in the budget allocation for healthcare in countries like Indonesia and Malaysia, further underscores the region's commitment to enhancing healthcare services.

Competitive Landscape

The competitive landscape of the Laparoscopy Devices Market is characterized by a mix of established players and emerging startups, each focusing on innovative features such as real-time tracking, integration with IoT devices, and user-friendly interfaces. Companies are increasingly investing in research and development to enhance product offerings and improve customer service, creating a dynamic and rapidly evolving market environment.

Some of the prominent players operating in the Laparoscopy Devices Market include Karl Storz SE & Co, Olympus Corporation, Medtronic plc, Braun Aesculap, Stryker Corporation, Richard Wolf GmbH, Ethicon Inc., Smith & Nephew plc, Cook Medical Incorporated, ConMed Corporation, Genesis MedTech, Johnson & Johnson, Boston Scientific Corporation, Shenzen Midray Bio-medical Electronics Co. Ltd., Microline Surgical.

Latest Developments

• In August 2024 Medtronic announced the launch of its new HARMONIC(TM) PRIME ultrasonic scalpel, designed to improve precision and control during laparoscopic surgeries. This device integrates advanced technology to minimize thermal spread and enhance tissue preservation, aligning with the growing demand for minimally invasive surgical solutions.
• In July 2024 Johnson & Johnson completed its acquisition of Auris Health, a robotics company focused on advancing minimally invasive surgical techniques. This acquisition aims to strengthen Johnson & Johnson's position in the laparoscopic devices market by integrating robotics with laparoscopic technology, allowing for enhanced surgical capabilities and improved patient outcomes.
• In June 2024 Stryker introduced its IMPACT(TM) 3D Camera System, which provides enhanced visualization and depth perception for surgeons during laparoscopic procedures. This system features advanced imaging technology that aids in better identification of anatomical structures, improving surgical precision and patient safety.

Laparoscopy Devices Market, By Category

• Type
• Laparoscopes
• Energy Devices
• Insufflators
• Access Devices
• Application
• Bariatric Surgery
• General Surgery
• Gynecological Surgery
• Urological Surgery
• End-User
• Hospitals
• Ambulatory Centers
• Geography:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL LAPAROSCOPY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL LAPAROSCOPY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL LAPAROSCOPY DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Laparoscopes
• 5.3 Energy Devices
• 5.4 Insufflators
• 5.5 Access Devices

6 GLOBAL LAPAROSCOPY DEVICES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Bariatric Surgery
• 6.3 General Surgery
• 6.4 Gynecological Surgery
• 6.5 Urological Surgery

7 GLOBAL LAPAROSCOPY DEVICES MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Centers

8 GLOBAL LAPAROSCOPY DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL LAPAROSCOPY DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Karl Storz SE & Co
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Olympus Corporation
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Medtronic plc
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Braun Aesculap
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Stryker Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Richard Wolf GmbH
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Ethicon Inc.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Smith & Nephew plc
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Cook Medical Incorporated
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 ConMed Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.11 Genesis MedTech
  • 10.11.1 Overview
  • 10.11.2 Financial Performance
  • 10.11.3 Product Outlook
  • 10.11.4 Key Developments
• 10.12 Johnson & Johnson
  • 10.12.1 Overview
  • 10.12.2 Financial Performance
  • 10.12.3 Product Outlook
  • 10.12.4 Key Developments
• 10.13 Boston Scientific Corporation
  • 10.13.1 Overview
  • 10.13.2 Financial Performance
  • 10.13.3 Product Outlook
  • 10.13.4 Key Developments
• 10.14 Shenzen Midray Bio-medical Electronics Co. Ltd.
  • 10.14.1 Overview
  • 10.14.2 Financial Performance
  • 10.14.3 Product Outlook
  • 10.14.4 Key Developments
• 10.15 Microline Surgical
  • 10.15.1 Overview
  • 10.15.2 Financial Performance
  • 10.15.3 Product Outlook
  • 10.15.4 Key Developments

11 Appendix

• 11.1 Related Research